Albert Einstein College of Medicine
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1955-01-01
- Employees
- 1.9K
- Market Cap
- -
- Website
- http://einstein.yu.edu
Safety and Efficacy of Apixaban in Severe Renal Impairment
Withdrawn
- Conditions
- First Posted Date
- 2018-01-16
- Last Posted Date
- 2022-08-26
- Lead Sponsor
- Albert Einstein College of Medicine
- Registration Number
- NCT03399305
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
MRI Only Radiation Therapy With CPAP
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2018-01-12
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 5
- Registration Number
- NCT03397342
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage
Phase 3
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2018-01-04
- Last Posted Date
- 2022-07-08
- Lead Sponsor
- Albert Einstein College of Medicine
- Registration Number
- NCT03390530
- Locations
- 🇺🇸
Praveen Ballabh, Bronx, New York, United States
Studies of Sulfur Metabolism in Humans
Early Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-12-26
- Last Posted Date
- 2023-10-27
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 1
- Registration Number
- NCT03383133
- Locations
- 🇺🇸
Albert Einstein Collage of Medicine, Bronx, New York, United States
A Trial of Directly Observed and Long-term Varenicline
Phase 4
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2017-12-07
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 243
- Registration Number
- NCT03365362
- Locations
- 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States
MEMO-Medical Marijuana and Opioids Study
Completed
- Conditions
- First Posted Date
- 2017-08-31
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 257
- Registration Number
- NCT03268551
- Locations
- 🇺🇸
Vireo Health, White Plains, New York, United States
🇺🇸Montefiore Health System, Bronx, New York, United States
Multicultural Healthy Diet to Reduce Cognitive Decline
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-08-07
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 393
- Registration Number
- NCT03240406
- Locations
- 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States
Low Dose Aprepitant for Patients Receiving Carboplatin
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2017-08-02
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 15
- Registration Number
- NCT03237611
- Locations
- 🇺🇸
Jacobi Medical Center, Bronx, New York, United States
🇺🇸Montefiore Medical Center, Bronx, New York, United States
Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2017-07-19
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 13
- Registration Number
- NCT03223103
- Locations
- 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States
Comparing Five Oral Analgesics for Treatment of Acute Pain in the Emergency Department (ED)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-06-01
- Last Posted Date
- 2022-02-01
- Lead Sponsor
- Albert Einstein College of Medicine
- Target Recruit Count
- 600
- Registration Number
- NCT03173456
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
© Copyright 2024. All Rights Reserved by MedPath